170 related articles for article (PubMed ID: 34541912)
1. A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation.
Shimshak SJE; Tolaymat LM; Haga CB; Dawson NL; Gillis MS; Yin M; Kirsch B; Cooper M; Sluzevich JC
J Cutan Med Surg; 2022; 26(2):169-175. PubMed ID: 34541912
[TBL] [Abstract][Full Text] [Related]
2. Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review.
Mahjoub TT; Milibary HH
J Cosmet Dermatol; 2023 Apr; 22(4):1157-1162. PubMed ID: 36575866
[TBL] [Abstract][Full Text] [Related]
3. The role of systemic treatments for skin lightening.
Juhasz MLW; Levin MK
J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
[TBL] [Abstract][Full Text] [Related]
4. Melasma Treatment: An Evidence-Based Review.
McKesey J; Tovar-Garza A; Pandya AG
Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
[TBL] [Abstract][Full Text] [Related]
5. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
6. The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence.
Masub N; Nguyen JK; Austin E; Jagdeo J
Dermatol Surg; 2020 Dec; 46(12):1642-1650. PubMed ID: 33252894
[TBL] [Abstract][Full Text] [Related]
7. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK
J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
Taraz M; Niknam S; Ehsani AH
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
[TBL] [Abstract][Full Text] [Related]
10. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
11. Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders.
Verma P; Yadav KS
Expert Opin Drug Deliv; 2023 Jun; 20(6):773-783. PubMed ID: 37086183
[TBL] [Abstract][Full Text] [Related]
12. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral tranexamic acid on erythema index in patients with melasma.
Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Insights in Melasma and Hyperpigmentation Management.
Huerth KA; Hassan S; Callender VD
J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
[TBL] [Abstract][Full Text] [Related]
15. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
Polat Y; Saraç G
Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
[TBL] [Abstract][Full Text] [Related]
17. Melasma: systematic review of the systemic treatments.
Zhou LL; Baibergenova A
Int J Dermatol; 2017 Sep; 56(9):902-908. PubMed ID: 28239840
[TBL] [Abstract][Full Text] [Related]
18. A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
Kwon HH; Ohn J; Suh DH; Park HY; Choi SC; Jung JY; Kwon IH; Park GH
J Dermatolog Treat; 2017 Mar; 28(2):155-159. PubMed ID: 27346606
[TBL] [Abstract][Full Text] [Related]
19. Treatment of melasma using tranexamic acid: what's known and what's next.
Sheu SL
Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
[TBL] [Abstract][Full Text] [Related]
20. Oral tranexamic acid for the treatment of melasma.
Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
